IBM/IMNM Fellowship
The IBM/IMNM Fellowship by The Myositis Association funds early-career researchers advancing science and care for inclusion body myositis and immune-mediated necrotizing myopathy.
Funder: The Myositis Association
Due Dates (Anticipated): May 2027 (Letter of Intent) | June 2027 (Full application)
Funding Amounts: $107,500 total, disbursed over 18–24 months
Summary: Supports early-career clinical and research trainees advancing understanding and care for inclusion body myositis (IBM) and immune-mediated necrotizing myopathy (IMNM).
Key Information: This is a forecasted opportunity; all dates are projected based on the annual cycle.
Description
The IBM/IMNM Fellowship, offered by The Myositis Association, supports clinical and research trainees specializing in neuromuscular medicine or related fields who are dedicated to advancing the understanding, prevention, detection, and treatment of inclusion body myositis (IBM) and immune-mediated necrotizing myopathy (IMNM). The fellowship encourages projects that not only address the biomedical aspects of these rare autoimmune neuromuscular disorders but also improve the quality of life for affected patients. Interdisciplinary and collaborative projects, especially those involving patient and care partner engagement, are particularly valued. The fellowship aims to foster the development of early-career investigators committed to a research or clinical practice focus on rare autoimmune diseases.
